650 related articles for article (PubMed ID: 32971089)
1. Integrative transcriptomics analysis of lung epithelial cells and identification of repurposable drug candidates for COVID-19.
Islam T; Rahman MR; Aydin B; Beklen H; Arga KY; Shahjaman M
Eur J Pharmacol; 2020 Nov; 887():173594. PubMed ID: 32971089
[TBL] [Abstract][Full Text] [Related]
2. Identification of host transcriptome-guided repurposable drugs for SARS-CoV-1 infections and their validation with SARS-CoV-2 infections by using the integrated bioinformatics approaches.
Ahmed FF; Reza MS; Sarker MS; Islam MS; Mosharaf MP; Hasan S; Mollah MNH
PLoS One; 2022; 17(4):e0266124. PubMed ID: 35390032
[TBL] [Abstract][Full Text] [Related]
3. A protein interaction map identifies existing drugs targeting SARS-CoV-2.
Cava C; Bertoli G; Castiglioni I
BMC Pharmacol Toxicol; 2020 Sep; 21(1):65. PubMed ID: 32883368
[TBL] [Abstract][Full Text] [Related]
4. Identification of a repurposed drug as an inhibitor of Spike protein of human coronavirus SARS-CoV-2 by computational methods.
Unni S; Aouti S; Thiyagarajan S; Padmanabhan B
J Biosci; 2020; 45(1):. PubMed ID: 33184246
[TBL] [Abstract][Full Text] [Related]
5. Targeting hub genes and pathways of innate immune response in COVID-19: A network biology perspective.
Prasad K; Khatoon F; Rashid S; Ali N; AlAsmari AF; Ahmed MZ; Alqahtani AS; Alqahtani MS; Kumar V
Int J Biol Macromol; 2020 Nov; 163():1-8. PubMed ID: 32599245
[TBL] [Abstract][Full Text] [Related]
6. Tiotropium is Predicted to be a Promising Drug for COVID-19 Through Transcriptome-Based Comprehensive Molecular Pathway Analysis.
Kang K; Kim HH; Choi Y
Viruses; 2020 Jul; 12(7):. PubMed ID: 32698440
[TBL] [Abstract][Full Text] [Related]
7. In silico prediction of potential inhibitors for the main protease of SARS-CoV-2 using molecular docking and dynamics simulation based drug-repurposing.
Kumar Y; Singh H; Patel CN
J Infect Public Health; 2020 Sep; 13(9):1210-1223. PubMed ID: 32561274
[TBL] [Abstract][Full Text] [Related]
8. Identification of SARS-CoV-2 Cell Entry Inhibitors by Drug Repurposing Using
Choudhary S; Malik YS; Tomar S
Front Immunol; 2020; 11():1664. PubMed ID: 32754161
[TBL] [Abstract][Full Text] [Related]
9. Differential Co-Expression Network Analysis Reveals Key Hub-High Traffic Genes as Potential Therapeutic Targets for COVID-19 Pandemic.
Hasankhani A; Bahrami A; Sheybani N; Aria B; Hemati B; Fatehi F; Ghaem Maghami Farahani H; Javanmard G; Rezaee M; Kastelic JP; Barkema HW
Front Immunol; 2021; 12():789317. PubMed ID: 34975885
[TBL] [Abstract][Full Text] [Related]
10. Structural and molecular basis of the interaction mechanism of selected drugs towards multiple targets of SARS-CoV-2 by molecular docking and dynamic simulation studies- deciphering the scope of repurposed drugs.
Skariyachan S; Gopal D; Chakrabarti S; Kempanna P; Uttarkar A; Muddebihalkar AG; Niranjan V
Comput Biol Med; 2020 Nov; 126():104054. PubMed ID: 33074111
[TBL] [Abstract][Full Text] [Related]
11. Protein Coding and Long Noncoding RNA (lncRNA) Transcriptional Landscape in SARS-CoV-2 Infected Bronchial Epithelial Cells Highlight a Role for Interferon and Inflammatory Response.
Vishnubalaji R; Shaath H; Alajez NM
Genes (Basel); 2020 Jul; 11(7):. PubMed ID: 32646047
[TBL] [Abstract][Full Text] [Related]
12. Transcriptional landscape of SARS-CoV-2 infection dismantles pathogenic pathways activated by the virus, proposes unique sex-specific differences and predicts tailored therapeutic strategies.
Fagone P; Ciurleo R; Lombardo SD; Iacobello C; Palermo CI; Shoenfeld Y; Bendtzen K; Bramanti P; Nicoletti F
Autoimmun Rev; 2020 Jul; 19(7):102571. PubMed ID: 32376402
[TBL] [Abstract][Full Text] [Related]
13. Discovery of common molecular signatures and drug repurposing for COVID-19/Asthma comorbidity: ACE2 and multi-partite networks.
Xu J; Abdulsalam Khaleel R; Zaidan HK; Faisal Mutee A; Fahmi Fawy K; Gehlot A; Abbas AH; Arias Gonzáles JL; Amin AH; Ruiz-Balvin MC; Imannezhad S; Bahrami A; Akhavan-Sigari R
Cell Cycle; 2024 Feb; 23(4):405-434. PubMed ID: 38640424
[TBL] [Abstract][Full Text] [Related]
14. In silico drug repurposing against SARS-CoV-2 using an integrative transcriptomic profiling approach: Hydrocortisone and Benzhydrocodone as potential drug candidates against COVID-19.
Mirmohammadi S; Kianmehr A; Sabbaghian A; Mohebbi A; Shahbazmohammadi H; Sheykharabi M; Bazzi Z
Infect Genet Evol; 2022 Sep; 103():105318. PubMed ID: 35718334
[TBL] [Abstract][Full Text] [Related]
15. Multi-omics-based identification of SARS-CoV-2 infection biology and candidate drugs against COVID-19.
Barh D; Tiwari S; Weener ME; Azevedo V; Góes-Neto A; Gromiha MM; Ghosh P
Comput Biol Med; 2020 Nov; 126():104051. PubMed ID: 33131530
[TBL] [Abstract][Full Text] [Related]
16. Old Drugs for a New Virus: Repurposed Approaches for Combating COVID-19.
Saul S; Einav S
ACS Infect Dis; 2020 Sep; 6(9):2304-2318. PubMed ID: 32687696
[TBL] [Abstract][Full Text] [Related]
17. Repurposing drugs against the main protease of SARS-CoV-2: mechanism-based insights supported by available laboratory and clinical data.
Chakraborti S; Bheemireddy S; Srinivasan N
Mol Omics; 2020 Oct; 16(5):474-491. PubMed ID: 32696772
[TBL] [Abstract][Full Text] [Related]
18. Transcriptome-based drug repositioning for coronavirus disease 2019 (COVID-19).
Jia Z; Song X; Shi J; Wang W; He K
Pathog Dis; 2020 Jun; 78(4):. PubMed ID: 32667665
[TBL] [Abstract][Full Text] [Related]
19. Interferon-Induced Transmembrane Protein (IFITM3) Is Upregulated Explicitly in SARS-CoV-2 Infected Lung Epithelial Cells.
Hachim MY; Al Heialy S; Hachim IY; Halwani R; Senok AC; Maghazachi AA; Hamid Q
Front Immunol; 2020; 11():1372. PubMed ID: 32595654
[TBL] [Abstract][Full Text] [Related]
20. SAveRUNNER: A network-based algorithm for drug repurposing and its application to COVID-19.
Fiscon G; Conte F; Farina L; Paci P
PLoS Comput Biol; 2021 Feb; 17(2):e1008686. PubMed ID: 33544720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]